Amgen has inaugurated its new drug substance facility in the US after announcing a $1bn further expansion at the North ...

Röchling Advent Tool & Mold has acquired the American medical technology specialist Precision Medical Products (PMP) based in Denver, Pennsylvania, US. The Röchling Group is consistently continuing ...

Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.

The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running ...

The FDA rejected the company’s initial NDA in 2021, citing the lack of an adequate trial to demonstrate efficacy.

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

Panellists at the World Economic Forum 2025 Davos meeting discussed how artificial intelligence (AI) could help close the gap ...

Emcure Pharmaceuticals has opened its new formulation research and development (R&D) centre at Ahmedabad, in the Indian state ...

The funding of up to £500,000 is provided by LifeArc, a medical research charity, to support the development of Glox’s ...

The year ahead in clinical trials looks set to be one that is challenged and influenced by regulatory developments, new ...

The US FDA has granted breakthrough therapy designation to Bluejay Therapeutics’ brelovitug, to treat chronic hepatitis delta ...